Business
Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)
STOCKHOLM, SE / ACCESS Newswire / May 6, 2026 /Today on 6 May 2026, the Annual General Meeting (the "AGM") of Vicore Pharma Holding AB (publ) ("Vicore Pharma" or the "Company")(STO:VICO) was held, whereby the shareholders passed the following resolutions. ...
About this update from Vicore Pharma Holding Ab
[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / May 6, 2026 / Today on 6 May 2026, the Annual General Meeting (the "AGM") of Vicore Pharma Holding AB (publ) ("Vicore Pharma" or the "Company")(STO:VICO) was held, whereby the shareholders passed the following resolutions.","length":286,"tagName":"p"},{"type":"text","content":"Adoption of the income statement and the balance sheetThe AGM resolved to adopt the income statement and the balance sheet and the consolidated income statement and the consolidated balance sheet for the financial year 2025.","length":225,"tagName":"p"},{"type":"text","content":"Allocation of profit or lossThe AGM resolved, in accordance with the Board of Directors' proposal, that no dividend shall be paid and that Vicore Pharma's results for the financial year 2025 shall be carried forward.","length":225,"tagName":"p"},{"type":"text","content":"Discharge from liabilityThe Board of Directors and the CEO were discharged from liability for the financial year 2025.","length":119,"tagName":"p"},{"type":"text","content":"Election of board members and auditors, and fees to the Board of Directors and auditorsThe AGM resolved, in accordance with the Nomination Committee's proposal, to re-elect Hans Schikan, Jacob Gunterberg, Elisabeth Björk, Heidi Hunter, Ann J. Barbier och Yasir Al-Wakeel as members of the Board of Directors and to elect Peter Guenter as new board member. Michael Buschle had declined re-election. Hans Schikan was re-elected as chairman of the Board of Directors. The registered audit firm Ernst & Young Aktiebolag was re-elected as the Company's auditor for the period until the end of the next Annual General Meeting.","length":633,"tagName":"p"},{"type":"text","content":"The AGM resolved, in accordance with the Nomination Committee's proposal, that the fees to the Board of Directors shall amount to SEK 3,010,000 in total (SEK 2,740,000 previous year) and be paid in accordance with the following, provided that the board members are not employees of the Company:","length":298,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"SEK 750,000 (SEK 700,000) to the chairman of the Board of Directors and SEK 270,000 (SEK 240,000) to each of the other board members;","length":133,"tagName":"p"}]},{"val":[{"type":"text","content":"SEK 160,000 (SEK 150,...